Drug: Bevacizumab Injury: Hypertension Quarter: 2016Q3
Total Records: 97 Number of Pages: 5
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 73762433 | Bevacizumab | Hypertension | ROCHE | 58.00 YR | F | 74 KG | 20160914 | US |
| 81331126 | Bevacizumab | Hypertension | ROCHE | 0.00 | F | 0 | 20160912 | US |
| 82290393 | Bevacizumab | Hypertension | ROCHE | 59.00 YR | F | 105 KG | 20160929 | US |
| 82619843 | Bevacizumab | Hypertension | ROCHE | 63.00 YR | F | 85 KG | 20160929 | US |
| 89228356 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160914 | US | |
| 91126278 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160928 | US | |
| 100108357 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160922 | US | |
| 101489614 | Bevacizumab | Hypertension | ROCHE | 70.00 YR | F | 56 KG | 20160919 | US |
| 105725032 | Bevacizumab | Hypertension | ROCHE | 71.12 YR | F | 88 KG | 20160929 | US |
| 107541674 | Bevacizumab | Hypertension | ROCHE | 66.00 YR | F | 80 KG | 20160905 | US |
| 107874456 | Bevacizumab | Hypertension | ROCHE | 71.00 YR | F | 62 KG | 20160829 | DE |
| 110923303 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160913 | IT | |
| 111343892 | Bevacizumab | Hypertension | ROCHE | 40.00 YR | M | 131 KG | 20160905 | US |
| 112613222 | BEVACIZUMAB | Hypertension | ASTELLAS | 49.92 YR | F | 0 | 20160930 | GB |
| 112726042 | Bevacizumab | Hypertension | ROCHE | 72.00 YR | F | 74 KG | 20160902 | US |
| 115525913 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160810 | JP | |
| 122161853 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160907 | JP | |
| 122249966 | Bevacizumab | Hypertension | ROCHE | 74.00 YR | M | 0 | 20160915 | DE |
| 124411593 | Bevacizumab | Hypertension | ROCHE | 50.00 YR | F | 84 KG | 20160711 | DE |
| 125232283 | BEVACIZUMAB | Hypertension | AMGEN | 58.00 YR | F | 0 | 20160802 | GB |
Total Records: 97 Number of Pages: 5